STOCK TITAN

Genelux Corp Financials

GNLX
FY2025 annual
Revenue $8K 0.0% YoY
Net Income -$32.1M -7.6% YoY
EPS (Diluted) -$0.86 +9.5% YoY
Free Cash Flow -$26.4M -22.0% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Genelux Corp (GNLX) reported $8K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GNLX FY2025

Genelux is still a capital-funded development-stage company, with operating burn overwhelming its almost nonexistent revenue base.

From FY2023 through FY2025, financing inflows totaled about $82.4M while operating cash outflow totaled about $66.8M. That cash support explains why liquidity and equity recovered from FY2022’s distressed position even though revenue stayed effectively immaterial; balance-sheet repair came from fundraising, not self-funded operations.

The losses are cash losses, not mainly accounting noise: FY2025 net loss of $32.1M was close to operating cash burn of $25.3M. Depreciation was only $244K, and free cash flow was -$26.4M, so the burn reflects paying today’s research and administrative costs rather than a capex-heavy buildout.

The cleaner balance sheet also came with a much larger share count, rising from 9.1M to 38.1M shares between FY2022 and FY2025, which shows external capital has been the main fuel rather than revenue-funded growth. Liquidity is better than in FY2022, but cash of $5.3M remains small against FY2025 operating burn of $25.3M, leaving the company reliant on outside funding to sustain the current cost base.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Genelux Corp does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress
-16.41

Genelux Corp scores -16.41, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($120.4M) relative to total liabilities ($7.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
2/7

Genelux Corp passes 2 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Genelux Corp reported a net loss of $32.1M while operations used $25.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$8K
YoY0.0%

Genelux Corp generated $8K in revenue in fiscal year 2025. That is unchanged from the prior year.

EBITDA
-$33.0M
YoY-4.8%

Genelux Corp's EBITDA was -$33.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 4.8% from the prior year.

Net Income
-$32.1M
YoY-7.6%

Genelux Corp reported -$32.1M in net income in fiscal year 2025. This represents a decrease of 7.6% from the prior year.

EPS (Diluted)
-$0.86
YoY+9.5%

Genelux Corp earned -$0.86 per diluted share (EPS) in fiscal year 2025. This represents an increase of 9.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$26.4M
YoY-22.0%

Genelux Corp recorded an outflow of $26.4M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 22.0% from the prior year.

Cash & Debt
$5.3M
YoY-37.7%

Genelux Corp held $5.3M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
45M
YoY+29.5%

Genelux Corp had 45M shares outstanding in fiscal year 2025. This represents an increase of 29.5% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity
-278.5%
YoY-164.8pp

Genelux Corp's ROE was -278.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 164.8 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$19.9M
YoY+4.5%

Genelux Corp invested $19.9M in research and development in fiscal year 2025. This represents an increase of 4.5% from the prior year.

Capital Expenditures
$1.1M
YoY+188.2%

Genelux Corp invested $1.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 188.2% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

GNLX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GNLX quarterly income statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
R&D Expenses$6.5M+12.6%$5.8MN/A$4.7M-0.4%$4.8M+1.3%$4.7MN/A$4.1M
SG&A Expenses$3.1M-7.5%$3.4MN/A$3.5M+13.8%$3.0M-2.7%$3.1MN/A$2.9M
Operating Income-$9.6M-5.2%-$9.2MN/A-$8.2M-5.2%-$7.8M+0.3%-$7.8MN/A-$6.9M
Net Income-$9.5M-6.1%-$8.9MN/A-$8.0M-6.6%-$7.5M+0.5%-$7.5MN/A-$6.5M
EPS (Diluted)-$0.21-5.0%-$0.20+16.7%-$0.24-14.3%-$0.21-5.0%-$0.20+4.8%-$0.21+19.2%-$0.26-36.8%-$0.19

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Interest Expense, Income Tax.

GNLX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GNLX quarterly balance sheet
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Total Assets$26.2M-19.1%$32.4M+70.1%$19.0M-23.9%$25.0M-22.5%$32.2M-17.3%$39.0M+12.3%$34.7M-13.8%$40.3M
Current Assets$19.1M-28.4%$26.8M+76.8%$15.1M-29.8%$21.6M-26.3%$29.2M-18.7%$35.9M+13.9%$31.5M-12.3%$36.0M
Cash & Equivalents$9.2M-1.0%$9.3M+73.9%$5.3M+13.7%$4.7M-28.3%$6.5M-59.6%$16.2M+89.2%$8.6M+40.4%$6.1M
Total Liabilities$10.1M+6.8%$9.5M+26.3%$7.5M+17.0%$6.4M-23.4%$8.3M-8.6%$9.1M+8.3%$8.4M+17.6%$7.2M
Current Liabilities$8.0M+10.0%$7.3M+16.8%$6.2M+21.4%$5.1M-26.6%$7.0M-9.1%$7.7M+11.4%$6.9M+24.3%$5.6M
Total Equity$16.1M-29.7%$22.9M+98.6%$11.5M-37.9%$18.6M-22.2%$23.9M-19.9%$29.8M+13.6%$26.3M-20.6%$33.1M
Retained Earnings-$301.9M-3.2%-$292.5M-3.1%-$283.5M-3.4%-$274.3M-3.0%-$266.3M-2.9%-$258.9M-3.0%-$251.4M-3.7%-$242.4M

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

GNLX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GNLX quarterly cash flow statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Cash Flow-$6.4M-6.4%-$6.1M+2.3%-$6.2M+5.7%-$6.6M+6.9%-$7.1M-29.9%-$5.4M-26.3%-$4.3M+25.2%-$5.7M
Capital Expenditures$1.5M+66.3%$921K+111.2%$436K-15.7%$517K+349.6%$115K+283.3%$30K-68.8%$96K+255.6%$27K
Free Cash Flow-$8.0M-14.3%-$7.0M-5.2%-$6.6M+6.4%-$7.1M+1.1%-$7.2M-31.3%-$5.5M-24.3%-$4.4M+23.8%-$5.8M
Investing Cash Flow$6.0M+169.9%-$8.5M-230.1%$6.6M+39.0%$4.7M+277.9%-$2.7M-175.6%$3.5M-47.4%$6.7M+67.2%$4.0M
Financing Cash Flow$387K-97.9%$18.5M+6616.7%$276K$0-100.0%$52K-99.5%$9.6M+10413.2%$91K$0

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

GNLX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

GNLX quarterly financial ratios
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Return on Equity-58.8%-19.8pp-39.0%N/A-42.8%-11.6pp-31.2%-6.1pp-25.1%N/A-19.5%
Return on Assets-36.1%-8.6pp-27.6%N/A-31.8%-8.7pp-23.1%-3.9pp-19.2%N/A-16.1%
Current Ratio2.39-1.3x3.68+1.2x2.43-1.8x4.200.0x4.18-0.5x4.67+0.1x4.57-1.9x6.47
Debt-to-Equity0.63+0.2x0.41-0.2x0.65+0.3x0.340.0x0.350.0x0.310.0x0.32+0.1x0.22

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

What is Genelux Corp's annual revenue?

Genelux Corp (GNLX) reported $8K in total revenue for fiscal year 2025. That is unchanged from the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Genelux Corp's revenue growing?

Genelux Corp (GNLX) revenue was essentially unchanged year-over-year, at $8K in fiscal year 2025 against $8K the year before.

Is Genelux Corp profitable?

No, Genelux Corp (GNLX) reported a net income of -$32.1M in fiscal year 2025.

Genelux Corp (GNLX) reported diluted earnings per share of -$0.86 for fiscal year 2025. This represents a 9.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Genelux Corp (GNLX) had EBITDA of -$33.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Genelux Corp (GNLX) has a return on equity of -278.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Genelux Corp (GNLX) recorded an outflow of $26.4M in free cash flow during fiscal year 2025. This represents a -22.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Genelux Corp (GNLX) recorded an outflow of $25.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Genelux Corp (GNLX) had $19.0M in total assets as of fiscal year 2025, including both current and long-term assets.

Genelux Corp (GNLX) invested $1.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Genelux Corp (GNLX) invested $19.9M in research and development during fiscal year 2025.

Genelux Corp (GNLX) had 45M shares outstanding as of fiscal year 2025.

Genelux Corp (GNLX) had a current ratio of 2.43 as of fiscal year 2025, which is generally considered healthy.

Genelux Corp (GNLX) had a debt-to-equity ratio of 0.65 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Genelux Corp (GNLX) had a return on assets of -168.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Genelux Corp (GNLX) held $5.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $25.3M over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Genelux Corp (GNLX) has an Altman Z-Score of -16.41, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Genelux Corp (GNLX) has a Piotroski F-Score of 2 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Genelux Corp (GNLX) reported a net loss of $32.1M while operations used $25.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top